Soleno Therapeutics Announces Presentations at ENDO 2022
REDWOOD CITY, Calif., June 07, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing...
Day: June 7, 2022
Singular Genomics and Olink Collaborate to Enable Olink® Explore on the G4 Max Read™ Sequencing Kits
Max Read kits on the G4 Sequencing Platform will produce up to 4 billion reads per run, enabling high throughput,...
Jasper Therapeutics to Participate in the William Blair 42nd Annual Growth Stock Conference
REDWOOD CITY, Calif., June 07, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling...
AUM Biosciences Announces FDA IND Authorization for Global Phase 2 Trial of Selection Translation Inhibitor AUM001 in Colorectal Cancer
SINGAPORE and BETHESDA, Md., June 07, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences, a global clinical-stage biotech company, focused on discovering...
eFFECTOR Therapeutics to Present at JMP Securities Life Sciences Conference
SAN DIEGO and REDWOOD CITY, Calif., June 07, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a biopharmaceutical company...
DLH-Supported Project Named 2022 FedHealthIT Innovation Award Winner
DLH-Supported Project Team Successfully Connects Supply-Chain Management IT SystemsATLANTA, June 07, 2022 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC)...
Ashvattha Therapeutics Announces Poster Presentation of Preclinical Data on Hydroxyl Dendrimer-Based Therapeutics at the 2022 Neurofibromatosis (NF) Conference
Scientific collaborators at Indiana University School of Medicine will present preclinical data demonstrating Ashvattha’s hydroxyl dendrimer-based therapeutics reduce toxicity in...
Aquestive Therapeutics to Participate in JMP Securities Life Sciences Conference
WARREN, N.J., June 07, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve...
Ascendis Pharma A/S Announces Two Oral Presentations Highlighting the Potential for TransCon™ PTH to be a Replacement Therapy for Adult Hypoparathyroidism at ENDO 2022
– Late-breaker oral presentation of TransCon PTH Phase 3 PaTHway Trial data in adult hypoparathyroidism on Tuesday, June 14 – Oral...
iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Highlight ProFound AI Risk
Leading experts, including distinguished researchers from the Karolinska Institutet and clinicians using it in daily practice, to discuss significant impact...
Science 37® to Participate in Upcoming Investor Conferences
RESEARCH TRIANGLE PARK, N.C., June 07, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial...
Novozymes extends the lifetime of textiles with sustainable innovation
AdobeStock_436255963 Biopolishing for MMCF is not just a quality win in terms of pilling performance. It also delivers excellent drapability...
Mindset Pharma to Participate in Upcoming Conferences in June 2022
TORONTO, June 07, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"),...
Tilray Medical Launches Sleep-Oriented CBN Night Oil for Medical Cannabis Patients in Canada
Aphria Medical CBN Oil New Aphria CBN Night Oil formulated for night-time useLEAMINGTON, Ontario, June 07, 2022 (GLOBE NEWSWIRE) --...
Acerus Announces Amendment and Restatement of the Promissory Note Related to the Up-Front Fee Payable to Former Serenity Securityholders
TORONTO, June 07, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCD) today announced that it...
Medicenna to Announce Fiscal Year 2022 Financial Results and Operational Highlights on Wednesday, June 22, 2022
TORONTO and HOUSTON, June 07, 2022 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or “the Company") (NASDAQ: MDNA TSX: MDNA),...
Brooklyn ImmunoTherapeutics Announces Board Changes
SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company focused...
Quipt Expands in California with Acquisition of NorCal Respiratory Reaching 90 Locations Nationwide
Acquisition Adds $3.2 Million in Annualized Revenues, Over 650K Adjusted EBITDA Post IntegrationCINCINNATI, June 07, 2022 (GLOBE NEWSWIRE) -- Quipt...
Crinetics Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference
SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery,...
Inozyme Pharma Appoints Kurt Gunter, M.D., as Chief Medical Officer
BOSTON, June 07, 2022 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel...